Tenaya is finalizing a shift to an asset-light operational model. By taking a one-time loss of roughly $2 million to shed a long-term lease obligation, they are reducing future cash burn while relying on existing inventory to sustain their current gene therapy pipeline
Tenaya has 4 business days to file the disclosure.
Lets see what brings...
Keep an eye on
https://www.sec.gov/edgar/search/#/q=TNYA&dateRange=custom&startdt=2026-06-30&enddt=2027-12-01
Tenaya Therapeutics (NASDAQ:TNYA) appointed Eric Hyllengren as Chief Financial Officer effective July 13, 2026. He will lead financial strategy, capital allocation, investor relations and corporate development.
Cash Compensation: An annual base salary of $490,000, plus eligibility for a 40% target annual bonus.
Equity Options: An inducement grant of options to purchase 1,650,000 shares of Tenaya's common stock.
Vesting Schedule: The options have a 10-year term and vest over four years (25% after the first year, and 1/48th monthly thereafter).
Severance: Eligibility for the company's Executive Change in Control and Severance Plan at the Tier 2 level.
​
Right now, the tight margin between the $0.70 strike price and the actual trading price creates a strong mechanical and psychological gravitational pull on the stock. Here is what is happening behind the scenes leading up to June 30th:
Arbitrage and Selling Pressure: Warrant holders looking to lock in a guaranteed profit will exercise their warrants at $0.70 and immediately sell the resulting common stock on the open market at $0.73. This creates a natural "ceiling" on the stock price because any upward momentum is met with immediate selling volume from players scraping that tiny spread.
Hedging Mechanics: Institutional investors often short the underlying stock against their long warrant positions to lock in gains early. This mechanical shorting adds temporary downward pressure.
The Overhang Discount: The market dislikes a looming supply shock. Knowing that a fresh block of cheap shares could suddenly expand the public float acts as a damper on new institutional buyers, who often choose to sit on the sidelines until the expiration date passes.
What Normally Happens After Expiration?
Once the June 30th deadline hits at 5:00 PM ET, the artificial trading dynamics vanish. The aftermath depends entirely on whether the stock finishes above or below the strike price
Chances of a reverse split?
If so, when would it be announced?